Inve US ▾
HRHR

Healthcare Realty (HR) Q1 FY26 earnings call: guidance and Q&A

Earnings call· Mar 2026 (Q1 FY26)· Real Estate· May 1, 2026

Source: earnings call transcript

Executive summary

Healthcare Realty Q1 FY26 — Strong Performance Drives Raised Guidance and Strategic Capital Allocation

Healthcare Realty delivered a strong Q1 FY26, exceeding expectations with record leasing activity and same-store NOI growth, prompting an early-year guidance raise. The company is actively executing its 'Healthcare Realty 2.0' strategy, focusing on organic growth drivers and disciplined capital allocation across stock buybacks, joint venture acquisitions, and redevelopments. Management expressed confidence in achieving mid-single-digit core earnings growth, aiming to redefine the sector's growth profile.

Highlights

5
  • Same-store NOI growth of nearly 7% (an all-time high) in Q1 FY26, leading to raised full-year guidance.

  • Signed over 2 million square feet of leases, an all-time high, with annual escalators averaging 3.1% and cash leasing spreads of 4.2%.

  • Same-store occupancy improved by 110 basis points year-over-year to 92.3%.

  • Repurchased $100 million of stock year-to-date at a weighted average price of $17.38, with $400 million remaining authorization.

  • Secured a new $400 million unsecured delayed draw term loan at SOFR plus 90 basis points, derisking a $600 million bond maturity.

Concerns

2
  • 13% of lease renewals had negative spreads, though management noted these were strategic decisions for overall IRR.

  • The 10-year treasury rate is at 4.3%, impacting the historical low-risk appeal of medical office properties.

Guidance & targets

CategoryTargetConfidence
Normalized FFO per share
$1.59 to $1.65
high materiality
High
Same-store cash NOI growth
3.75% to 4.75%
high materiality
High
Capital allocation to KKR joint venture
$50 million to $100 million
medium materiality
Medium
Year-end leverage target
mid-5x area
high materiality
High
Core earnings growth (excluding 2025 dilution)
above 5%
high materiality
High
Disposition program progress
halfway towards midpoint of target
medium materiality
High

Segment performance

SegmentRevenueYoYQoQMargin
Same-store portfolio
Achieved an all-time high for same-store NOI growth, driven by occupancy gains and margin expansion. Q1 had an easier year-over-year comparison.
Occupancy: 92.3%Occupancy YoY increase: 110 bpsCash leasing spreads: 4.2%NOI included in same-store pool: 95%
—6.9%—60 bps expansion

HR operating KPIs by quarter

HR operating KPIs stated on its earnings calls, by fiscal quarter
KPIThis call Mar 2026 Q1 FY26 Jun 2026 Q2 FY26Change vs prior quarter
Retention rate
93.5% During the first quarter, our retention rate was 93.5%. Source: earnings call transcript
88.5% Tenant retention was a standout at 88.5%, helping drive approximately 25 basis points of absorption and lifting same-store occupancy to nearly 93%. Source: earnings call transcript
-5 pt
Capital expenditures Redevelopment portfolio
$25M We bought back $100 million of stock, we completed in excess of $20 million of acquisitions and we invested $25 million in our redevelopment portfolio. Source: earnings call transcript
~$25M During the quarter, we invested approximately $25 million in this portfolio, and we have leased it up to 67% an improvement of 1,400 basis points over the last 4 quarters. Source: earnings call transcript
—
Properties Redevelopment
23 Third, redevelopment, which currently consists of 23 properties that are 64% pre-leased. Source: earnings call transcript
~25 We've got around 25 assets in redevelopment today. Source: earnings call transcript
—

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Orderbook & backlog

Signed Not Occupied (SNO) pipeline 490,000 sq ft Q1 FY26

Substantial amount (nearly half) is in the lease-up redevelopment bucket, expected to drive occupancy gains.

New leasing pipeline 1.4 million sq ft Q1 FY26

Robust pipeline, a good leading indicator for future occupancy gains.

Deals & partnerships

KKR Growth JV for external acquisitions

Currently encompasses 5% of total NOI. Management sees ample room for this to grow and expects to allocate $50 million to $100 million of capital in 2026.

Wellstar New and renewal leases for clinical space average term of 5 years

176,000 square feet across 6 on-campus buildings in Atlanta, including a 59,000 sq ft cancer center. Wellstar is an A+ credit rated health system.

Advocate Health Renewal leases for clinical space more than 7 years

6 renewal leases totaling 154,000 square feet in Charlotte. Advocate Health is a AA credit rated health system with over 50% market share.

Trinity Health St. Peter's Hospital Lease for clinical and surgery center space nearly 6.5 years

64,000 square feet in Upstate New York. Trinity Health is a top 10 national health system with a AA- credit rating.

MUSC Health Renewal leases 9 years

3 lease renewals for 55,000 square feet in Charleston, maintaining 100% occupancy across 2 buildings. MUSC is South Carolina's only comprehensive academic health system.

Undisclosed JV partner Acquisition $18 million

Pro rata share of a JV acquisition closed at quarter-end.

Capital programs

Redevelopment portfolio NOI upside underway $50 million

Benefit:NOI upside

Primary source of NOI upside in the company's 3-year forecast, tracking ahead of schedule.

Tufts Medical Center MOB redevelopment (Boston) underway $25 million
Start: Q1 FY26

Benefit:155,000 sq ft MOB, 100% pre-leased with 10-year term and 3% annual escalators

New project added in Q1, connected to Tufts Medical Center.

Novant Health Huntersville Medical Center MOB project (Charlotte) completed $35 million
Start: Q1 FY26

Benefit:2 MOB buildings, 98% leased with stabilized yield of 9% to 12%

Completed in Q1, adjacent to Novant Health Huntersville Medical Center. Will move into same-store after a full calendar year since completion.

Unsecured delayed draw term loan nearing completion $400 million
Funding: Bank partnerships

Benefit:Liquidity to repay $600 million bond maturity

Fully committed facility, expected to close in May. Drawn pricing at SOFR plus 90 basis points, all-in pricing approximately 4.8%.

Risks & headwinds

Deceleration in same-store NOI growth Remaining quarters of FY26

Implied by full-year guidance (3.75%-4.75%) compared to Q1 (6.9%)

Mitigation:Management views guidance as conservative with potential for further raises; expects continued strong growth, though Q1 benefited from easier comps.

Negative lease renewal spreads Ongoing

13% of Q1 renewals had negative spreads

Mitigation:Strategic decision to retain tenants when overall lease IRR is better than re-leasing costs (downtime, CapEx). Management focuses on blended numbers and overall financial package.

Impact of higher interest rates Ongoing

10-year treasury at 4.3% today

Mitigation:Company secured a new delayed draw term loan at 4.8% (below 5% assumption) and extended swaps at 3.3% SOFR, derisking debt maturities and managing cost of debt.

What to watch in Q2 FY26

Same-store NOI growth

Q2 FY26 results
Current 6.9% (Q1 FY26)
Target Closer to Q1 level, or above current FY26 guidance midpoint of 4.25%

Why it matters

To confirm if Q1's strong performance was sustainable beyond easy comps and if management can raise full-year guidance further.

I don't really think about it necessarily as deceleration. I mean I think about it as an opportunity to raise guidance a few more times as the year progresses.

Find out whether HR delivers this. Inve re-checks your case every morning.

Q&A highlights

Given the 6.9% same-store NOI growth in Q1, why is the full-year guidance more conservative, implying deceleration? Was Q1 driven by easy comps?

Management acknowledged the strong Q1 was partly due to easier year-over-year comps but views the full-year guidance as an opportunity to raise it further. They expect continued strong growth, though perhaps not at the nearly 7% level, and noted the previous year's Q1 was tough.

“I don't really think about it necessarily as deceleration. I mean I think about it as an opportunity to raise guidance a few more times as the year progresses. So I like to look at it as the glass is half-full, not necessarily the glass is half-empty.”

asked by William John Kilichowski · answered by Peter Scott

2 min read 6 chapters

Detailed narrative

Healthcare Realty 2.0 Strategy and Performance

CEO Pete Scott highlighted significant progress in the year since assuming his role, transforming the company into 'Healthcare Realty 2.0' with revamped operations and a rightsized balance sheet. The Q1 FY26 results, including record leasing and same-store NOI growth, are seen as a solid foundation for outperformance against the 3-year earnings forecast.

The company aims to redefine success in the outpatient medical sector, moving beyond the 'Steady Eddie' stereotype.

Organic Growth Pillars

The company's organic growth strategy is built on four pillars: occupancy, annual escalators, retention rate, and cash leasing spreads. Same-store occupancy improved to 92.3% (up 110 bps YoY), with total occupancy at 90.5%. Average annual escalators on new leases are over 3%, contributing to the portfolio's $650 million NOI.

Retention rate was 93.5%, reducing downtime and capital expenditures. Cash leasing spreads averaged 4.2%, with 1 in 4 leases exceeding 5%.

Capital Allocation and External Growth

Healthcare Realty maintains a disciplined capital allocation approach, focusing on stock buybacks, joint venture acquisitions, and redevelopments. In Q1, the company repurchased $100 million of stock, completed $20 million in JV acquisitions (pro rata share $18 million), and invested $25 million in redevelopments.

The company has $400 million in buyback capacity remaining and expects to allocate $50 million to $100 million to its KKR joint venture in FY26, targeting initial cash yields greater than 7%.

Redevelopment Portfolio Progress

The redevelopment portfolio, consisting of 23 properties, is 64% pre-leased and is a primary source of $50 million NOI upside in the 3-year forecast. The lease percentage in this portfolio gained 900 basis points sequentially. Two new projects were added in Q1, including a $25 million redevelopment in Boston (100% pre-leased) and a $35 million project in Charlotte (98% leased with a 9-12% stabilized yield).

The average cash-on-cash yield for the redevelopment portfolio is 10%.

Balance Sheet and Liquidity

The company reported normalized FFO per share of $0.41 and FAD per share of $0.32. A new $400 million unsecured delayed draw term loan is expected to close in May at SOFR + 90 bps, with an all-in pricing of approximately 4.8%, below the 5% cost of debt assumption.

This facility will help repay a $600 million bond maturity in August. The company also launched a commercial paper program with $250 million outstanding and extended $400 million of swaps to 2029 at SOFR 3.3%.

Market Fundamentals and Health System Relationships

Demand for medical outpatient buildings remains robust, with favorable sector fundamentals including absorption outstripping completions and rising rental rates. Health systems are investing in higher-margin outpatient services, leading to increased activity. Notable health system leasing activity included 176,000 sq ft with Wellstar in Atlanta, 154,000 sq ft with Advocate Health in Charlotte, 64,000 sq ft with Trinity Health in Upstate New York, and 55,000 sq ft with MUSC Health in Charleston.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.